Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07281742 · ClinicalTrials.gov registry record · NA

Amblyopia Treatment for Children Aged 8 to 12 Years

A NA study of Amblyopia, sponsored by Retina Foundation of the Southwest.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT07281742 is a NA study of Amblyopia that is actively recruiting participants, run by Retina Foundation of the Southwest. The registered enrollment target is 30 participants, below the 164-participant average among 24 other Amblyopia trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07281742, a NA study of Amblyopia, is actively recruiting participants, sponsored by Retina Foundation of the Southwest.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This study is being done to assess the effect of at-home amblyopia treatment with Curesight™ for children aged 8 to 12 years. Curesight™ allows you to stream any videos on a computer screen at home but the amblyopic eye will see the entire screen clearly while part of the image will be blurred for the other eye. There is already a pivotal clinical trial showing that this treatment is effective for young children and Curesight™ has been cleared for use as an amblyopia treatment by the FDA for children as young as 4 years.

Conditions Studied

Interventions

  • DEVICE Curesight dichoptic videos

Study Locations (1)

Texas

  • Retina Foundation of the Southwest - Dallas

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-01-07
Est. Completion 2028-06-30
Phase NA

Sponsor

Retina Foundation of the Southwest

11 total trials

What the Registry Record Tells You About NCT07281742

The ClinicalTrials.gov registry entry for NCT07281742 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 164-participant average among 24 other Amblyopia trials with a reported enrollment target (82% lower). The listed sponsor is Retina Foundation of the Southwest, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Amblyopia appearing as the primary indexed condition, and to 1 intervention - of which Curesight dichoptic videos is the first listed.

NCT07281742 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT07281742 about?

NCT07281742 is a clinical study titled "Amblyopia Treatment for Children Aged 8 to 12 Years". This study is being done to assess the effect of at-home amblyopia treatment with Curesight™ for children aged 8 to 12 years. Curesight™ allows you to stream any videos on a computer screen at home but the amblyopic eye will see the entire screen clearly while part of the image will be blurred for t...

What is the current status of trial NCT07281742?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-01-07. Estimated completion is 2028-06-30.

What conditions does trial NCT07281742 study?

This clinical trial studies the following conditions: Amblyopia.

What interventions are being tested in trial NCT07281742?

The interventions under investigation include: Curesight dichoptic videos (DEVICE).

Who is sponsoring clinical trial NCT07281742?

This trial is sponsored by Retina Foundation of the Southwest, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07281742 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amblyopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.